Cancer
Survivin 93–101 mutant (HLA-A*01:01) 94T FTELTLGEF
Product number: EP11421_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide Survivin 93–101 mutant (HLA-A*01:01) 94T with the amino acid sequence FTELTLGEF is a linear peptidic epitope (epitope ID 1330459) studied as part of Baculoviral IAP repeat-containing protein 5 (UniProt:O15392) from Homo sapiens (human).
The epitope is an analog of: FEELTLGEF from Homo sapiens (human) survivin-beta [Homo sapiens].
Survivin 93–101 mutant (HLA-A*01:01) 94T has been studied for immune reactivity in publications and has been tested in T cell assays.
TechData
| Sequence: | FTELTLGEF |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Survivin |
| Species: | Human |
| Allele: | HLA-A*01:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |